| Date Filed | Type | Description |
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
4
| Sitar Edward J (Director) has filed a Form 4 on Timber Pharmaceuticals, Inc.|
Txns:
| Granted 2,500 shares
@ $1.629, valued at
$4.1k
|
|
| 04/19/2022 |
4
| Sitar Edward J (Director) has filed a Form 4 on Timber Pharmaceuticals, Inc.|
Txns:
| Granted 150,000 shares
@ $0
Granted 150,000 options to buy
@ $0.307, valued at
$46.1k
|
|
| 11/24/2021 |
4
| Sitar Edward J (Director) has filed a Form 4 on Timber Pharmaceuticals, Inc.|
Txns:
| Bought 15,000 shares
@ $0.46, valued at
$6.9k
|
|
| 09/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2020 |
4
| Sitar Edward J (CFO) has filed a Form 4 on 9 METERS BIOPHARMA, INC.|
Txns:
| Bought 61,538 shares
@ $0.65, valued at
$40k
|
|
| 07/08/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2020 |
4
| Sitar Edward J (Director) has filed a Form 4 on Timber Pharmaceuticals, Inc.|
Txns:
| Granted 24,270 options to buy
@ $2.87, valued at
$69.7k
|
|
| 05/20/2020 |
3
| Sitar Edward J (Director) has filed a Form 3 on Timber Pharmaceuticals, Inc. |
| 05/04/2020 |
4
| Sitar Edward J (CFO) has filed a Form 4 on INNOVATE BIOPHARMACEUTICALS, INC.|
Txns:
| Bought 678 convertible preferred
@ $0
Bought 678 options to buy
@ $0 |
|
| 05/04/2020 |
4
| Sitar Edward J (CFO) has filed a Form 4 on INNOVATE BIOPHARMACEUTICALS, INC.|
Txns:
| Granted 176,156 options to buy
@ $0.6, valued at
$105.7k
Granted 125,000 options to buy
@ $0.7, valued at
$87.5k
|
|
| 07/03/2019 |
4
| Sitar Edward J (CFO) has filed a Form 4 on INNOVATE BIOPHARMACEUTICALS, INC.|
Txns:
| Granted 350,000 options to buy
@ $1.17, valued at
$409.5k
|
|
| 07/03/2019 |
3
| Sitar Edward J (CFO) has filed a Form 3 on INNOVATE BIOPHARMACEUTICALS, INC. |
| 11/16/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |